| Literature DB >> 30700257 |
Caoimhe Madden1,2, Sinéad Lydon3,4, Margaret E Cupples2,5,6, Nigel D Hart7, Ciara Curran1,4, Andrew W Murphy1,2, Paul O'Connor1,2,4.
Abstract
BACKGROUND: Patient safety research is conducted predominantly in hospital settings, with a dearth of insight from primary care, despite suggestions that 2.2% of primary care consultations result in a patient safety incident. This study aimed to assess the feasibility of an intervention intended to improve patient safety in general practice.Entities:
Keywords: Feasibility; General practice; Patient safety; Primary care; Randomised controlled trial; safety climate; safety culture
Mesh:
Year: 2019 PMID: 30700257 PMCID: PMC6352328 DOI: 10.1186/s12875-019-0909-8
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Fig. 1Flow diagram of the SAP-C feasibility study
Means, standard deviations, and effect sizes of Safety Climate (SC) subscale and total scores calculated for control and intervention practices
| Safety Climate scores: Control practices | Safety Climate scores: Intervention practices | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Managerial | Non-managerial | Managerial | Non-managerial | |||||||||
| T1 Mean (SD) | T2 Mean (SD) | da | T1 Mean (SD) | T2 Mean (SD) | da | T1 Mean (SD) | T2 Mean (SD) | da | T1 Mean (SD) | T2 Mean (SD) | da | |
| Workload | 3.48 (0.93) | 3.77 (1.34) | − 0.25 | 4.16 (1.37) | 4.20 (1.63) | −0.02 | 4.70 (1.22) | 4.88 (0.93) | −0.16 | 4.64 (1.09) | 5.12 (1.06) | −0.45 |
| Communication | 5.78 (0.89) | 5.07 (1.48) | 0.58 | 5.03 (1.46) | 5.05 (1.49) | −0.01 | 5.73 (0.97) | 6.00 (0.77) | −0.31 | 5.47 (1.19) | 5.78 (1.14) | −0.27 |
| Leadership | 6.24 (0.86) | 6.13 (0.78) | 0.13 | 5.90 (1.05) | 5.68 (1.48) | 0.17 | 6.29 (0.43) | 6.51 (0.55) | −0.45 | 6.07 (0.86) | 6.17 (1.16) | −0.10 |
| Teamwork | 5.62 (0.93) | 5.66 (1.13) | −0.0 | 5.81 (0.96) | 5.59 (1.04) | 0.21 | 6.16 (0.61) | 6.52 (0.56) | −0.61 | 6.09 (0.90) | 6.16 (0.81) | −0.08 |
| Safety systems | 5.79 (0.65) | 5.44 (0.95) | 0.43 | 5.28 (1.13) | 5.33 (1.27) | −0.04 | 5.87 (0.73) | 6.40 (0.52) | −0.84 | 6.01 (0.89) | 6.11 (0.83) | −0.12 |
| Total SC | 5.52 (0.63) | 5.34 (0.91) | 0.22 | 5.36 (0.91) | 5.21 (1.09) | 0.14 | 5.78 (0.57) | 6.15 (0.55) | −0.66 | 5.70 (0.70) | 5.94 (0.74) | −0.33 |
T1 = pre-test (baseline), T2 = post-test (end of study), d = Cohen’s d
ad represents the effect size of the difference between the scores at T1 and T2
Severity and preventability of patient safety incidents (n = 36) as identified by trigger tool
| Rating scale | Description | n (%) |
|---|---|---|
| Severity | ||
| 1 | Any incident with the potential to cause harm. | 10 (27.8) |
| 2 | Mild harm, inconvenience, further follow-up or investigation to ensure no harm occurred. | 13 (36.1) |
| 3 | Moderate harm: required intervention or duration for longer than a day. | 8 (22.2) |
| 4 | Prolonged, substantial or permanent harm, including hospitalisation. | 5 (13.9) |
| Preventability | ||
| 1 | Not preventable and originated in secondary care. | 2 (5.6) |
| 2 | Preventable and originated in secondary care OR not preventable and originated in primary care. | 10 (27.8) |
| 3 | Potentially preventable and originated in primary care. | 17 (47.2) |
| 4 | Preventable and originated in primary care. | 7 (19.4) |
Frequency and details of main types of patient safety incidents (n = 36) and the most common medications (n = 21) implicated
| PSI Characteristics | n (%) |
|---|---|
| Types of PSIsa: | |
| Medication | 21 (58.3%) |
| Monitoring | 15 (41.7%) |
| Diagnosis and diagnosing | 9 (25%) |
| Coding/record keeping | 7 (19.4%) |
| Investigations | 7 (19.4%) |
| Communication | 6 (16.6%) |
| Unclear/insufficient info to classify | 3 (8.3%) |
| Medications most commonly implicated in PSIsb: | |
| Diuretics | 8 (38.1%) |
| ACEI/ARBs | 3 (14.3%) |
| Opiates | 3 (14.3%) |
| Antibiotics | 2 (9.5%) |
| Warfarin | 2 (9.5%) |
| Other hypoglycaemic agents | 1 (4.8%) |
| NSAIDs including aspirin | 1 (4.8%) |
| Not specified | 3 (14.3%) |
Note. aFigures do not total to 36 as some PSIs fall within more than one of the categories
bFigures do not total to 21 as more than one medication was implicated in the instance of some PSIs
ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, NSAID nonsteroidal anti-inflammatory drug
Intervention Practice responses (N = 27) to statements in end-of study questionnaire
| Strongly disagree | Disagree | Neither agree nor disagree | Agree | Strongly agree | |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | N (%) | |
| Feedback on the safety climate survey was useful for improving patient safety. | 1 (3.7%) | 2 (7.4%) | 1 (3.7%) | 15 (55.6%) | 8 (29.6%) |
| Completing the survey helped me reflect on how we manage patient safety in this practice. | 1 (3.7%) | – | 1 (3.7%) | 16 (59.3%) | 9 (33.3%) |
| Feedback from the trigger tool chart audit was useful for improving patient safety. | 1 (3.7%) | – | 6 (22.2%) | 12 (44.4%) | 8 (29.6%) |
| Changes were made at this practice based upon the information obtained from this intervention. | 1 (3.7%) | 6 (22.2%) | 5 (18.5%) | 10 (37%) | 5 (18.5%) |
| Overall, I believe that this intervention had a positive effect on patient safety at this practice. | 2 (7.4%) | 3 (11.1%) | 4 (14.8%) | 11 (40.7%) | 7 (25.9%) |
| The effect of this intervention is worth evaluating as a randomised controlled trial. | 2 (7.4%) | – | 5 (18.5%) | 13 (48.1%) | 7 (25.9%) |